Pfizer Czech Republic made a net profit of CZK 103 mil in 2017, up 39.7% when compared to the last year. Total sales reached CZK 3,586 mil, which is up 10.6% when compared to the previous year.
Historically, the company’s net profit reached an all time high of CZK 272 mil in 2008 and an all time low of CZK -29.9 mil in 2005.
In terms of sales, Pfizer Czech Republic reached an all time high of CZK 6,807 mil in 2011 and an all time low of CZK 2,057 mil in 2003.
Pfizer Czech Republic's net profit has grown 16.4% a year on average in the last five years while sales have increased by 2.84% a year since 2012.
The firm generated its shareholders an average return on invested capital of 10.7% in the last five years.
As far as Pfizer Czech Republic's peers are concerned, Bayer Czech Republic posted a net profit and sales of CZK 106 mil and CZK 4,180 mil in 2017 and Amgen Czech Republic generated a net profit of CZK 37.8 mil (with sales of CZK 417 mil).
|Amgen Czech Republic||CZK mil||46.2||28.3||28.7||40.5||35.8|
|Bayer Czech Republic||CZK mil||166||83.4||96.2||107||123|
|GlaxoSmithKline Czech Republic||CZK mil||240||164||127||87.7||125|
|Merck Czech Republic||CZK mil||49.3||63.4||27.4||34.9||68.6|
|Novartis Czech Republic||CZK mil||41.7||50.0||52.3||82.2||82.7|
|Pfizer Czech Republic||CZK mil||231||48.1||144||134||75.4|
|Roche Czech Republic||CZK mil||50.5||38.7||135||94.9||51.0||...|
|Sanofi-Aventis Czech Republic||CZK mil||55.1||45.2||65.2||1.19||58.6|
|Servier Czech Republic||CZK mil||...||...||12.8||13.6||13.6||15.9|